当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 利润表

华北制药

(600812)

  

流通市值:101.57亿  总市值:101.57亿
流通股本:17.16亿   总股本:17.16亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入5,275,037,790.22,574,254,051.929,869,575,819.117,560,235,670.39
  营业收入5,275,037,790.22,574,254,051.929,869,575,819.117,560,235,670.39
二、营业总成本5,064,452,841.412,469,225,602.079,602,162,210.857,395,586,299.65
  营业成本3,712,471,185.761,816,338,278.926,714,658,593.445,272,198,266.78
  税金及附加58,901,920.8626,799,221.61109,275,550.5177,366,304.85
  销售费用682,307,914.65321,958,401.871,433,292,527.421,052,291,747.95
  管理费用264,978,738.01134,047,050.91581,885,940.9415,243,846.33
  研发费用169,073,874.0980,967,533.71337,275,440.94251,674,097.83
  财务费用176,719,208.0489,115,115.05425,774,157.64326,812,035.91
  其中:利息费用190,640,852.4197,396,371.32458,698,019.11345,915,986.61
  其中:利息收入13,034,013.736,554,100.0125,255,785.3218,449,560.56
三、其他经营收益
  加:投资收益26,285,765.547,596,720.8346,164,658.1833,415,822.41
  资产处置收益-9,846.674,253.94444,156.56440,884.14
  资产减值损失(新)7,432,452.046,614,126.09-16,374,073.778,350,790.94
  信用减值损失(新)-38,886,024.62-21,594,563.99-22,675,856-6,417,154.9
  其他收益8,366,394.15,266,449.3136,708,667.7122,655,374.24
四、营业利润213,773,689.18102,915,436.03311,681,160.94223,095,087.57
  加:营业外收入633,098.54375,653.516,936,839.193,339,164.23
  减:营业外支出370,543.27138,827.078,785,487.373,458,318.97
五、利润总额214,036,244.45103,152,262.47309,832,512.76222,975,932.83
  减:所得税费用51,749,387.8526,526,600.4894,865,994.4376,535,187.12
六、净利润162,286,856.676,625,661.99214,966,518.33146,440,745.71
(一)按经营持续性分类
  持续经营净利润162,286,856.676,625,661.99214,966,518.33146,440,745.71
(二)按所有权归属分类
  归属于母公司股东的净利润123,497,402.8957,491,586.04126,992,370.2102,463,641.21
  少数股东损益38,789,453.7119,134,075.9587,974,148.1343,977,104.5
  扣除非经常损益后的净利润119,946,433.6955,215,276.48112,879,831.2282,555,825.6
七、每股收益
  (一)基本每股收益0.070.030.070.06
  (二)稀释每股收益0.070.030.070.06
八、其他综合收益-412,469.0239,722.881,601,601.48-150,201.56
  归属于母公司股东的其他综合收益-412,469.0239,722.881,601,601.48-150,201.56
九、综合收益总额161,874,387.5876,665,384.87216,568,119.81146,290,544.15
  归属于母公司股东的综合收益总额123,084,933.8757,531,308.92128,593,971.68102,313,439.65
  归属于少数股东的综合收益总额38,789,453.7119,134,075.9587,974,148.1343,977,104.5
公告日期2025-08-142025-04-242025-03-282024-10-26
审计意见(境内)标准无保留意见
TOP↑